12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several health care stocks showed significant movement. Tilray Brands, Talaris Therapeutics, Aspira Womens Health, cbdMD, G Medical Innovations, and Erasca saw increases, while INVO Bioscience, XTL Biopharmaceuticals, Fresh Tracks Therapeutics, Armata Pharmaceuticals, PaxMedica, and BrainsWay experienced decreases.
July 26, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Armata Pharmaceuticals' shares declined by 6.1% to $1.85 during Wednesday's pre-market session.
The decrease in Armata Pharmaceuticals' stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
BrainsWay's shares fell 5.94% to $2.22 during Wednesday's pre-market session.
The decrease in BrainsWay's stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Fresh Tracks Therapeutics' shares decreased by 6.36% to $0.75 during Wednesday's pre-market session.
The decrease in Fresh Tracks Therapeutics' stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
INVO Bioscience's shares fell 10.2% to $0.14 during Wednesday's pre-market session.
The decrease in INVO Bioscience's stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
PaxMedica's stock fell 6.0% to $0.68 during Wednesday's pre-market session.
The decrease in PaxMedica's stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
XTL Biopharmaceuticals' stock decreased by 8.04% to $0.8 during Wednesday's pre-market session.
The decrease in XTL Biopharmaceuticals' stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Aspira Womens Health's stock rose 10.0% to $2.64 during Wednesday's pre-market session.
The rise in Aspira Womens Health's stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Erasca's stock rose 8.36% to $2.72 during Wednesday's pre-market session.
The rise in Erasca's stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
G Medical Innovations' stock rose 8.97% to $0.37 during Wednesday's pre-market session.
The rise in G Medical Innovations' stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Talaris Therapeutics' stock rose 12.27% to $3.28 during Wednesday's pre-market session.
The rise in Talaris Therapeutics' stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Tilray Brands' shares rose 17.9% to $1.98 during Wednesday's pre-market session following the release of their Q4 earnings report.
The rise in Tilray Brands' stock price is likely due to the release of their Q4 earnings report, which is typically a significant event for a company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
cbdMD's shares increased by 9.79% to $1.47 during Wednesday's pre-market session.
The rise in cbdMD's stock price is likely due to market dynamics and investor sentiment, as no specific news was mentioned.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100